Alto Neuroscience Inc.
ANRO
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.23B
Close$
$5.96
83.7% downside
Current Fair Value
83.7% downsideOvervalued by 83.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.23 Billion |
|---|---|
| Enterprise Value | $996.17 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.19 |
| Beta | 1.09 |
| Outstanding Shares | 42,813,000 |
Return
| Return on Equity | -38.42% |
|---|---|
| Return on Assets | -33.16% |
| Return on Invested Capital | -35.75% |
Valuation & Multiples
| P/E Ratio | -14.17 |
|---|---|
| PEG | -25.25 |
| Price to Sales | - |
| Price to Book Ratio | 7.33 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -11.74 |
| Enterprise Value to Net Income | -12 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$-0.62
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.67
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0339▲ 3.39% |
|---|---|
| Total Calls | 462,500▲ 4.28% |
| Total Puts | 15,700▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 92.99%▲ 7.39% |
|---|---|
| Total Invested | $602.48M▲ 34.91% |
| Investors Holding | 114▲ 13.00% |
ESG Score
No data